BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31311920)

  • 21. CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vector.
    Rakonczay Z; Hegyi P; Hasegawa M; Inoue M; You J; Iida A; Ignáth I; Alton EW; Griesenbach U; Ovári G; Vág J; Da Paula AC; Crawford RM; Varga G; Amaral MD; Mehta A; Lonovics J; Argent BE; Gray MA
    J Cell Physiol; 2008 Feb; 214(2):442-55. PubMed ID: 17654517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The duct cell in cystic fibrosis.
    Harris A
    Ann N Y Acad Sci; 1999 Jun; 880():17-30. PubMed ID: 10415847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-cell-resolved differentiation of human induced pluripotent stem cells into pancreatic duct-like organoids on a microwell chip.
    Wiedenmann S; Breunig M; Merkle J; von Toerne C; Georgiev T; Moussus M; Schulte L; Seufferlein T; Sterr M; Lickert H; Weissinger SE; Möller P; Hauck SM; Hohwieler M; Kleger A; Meier M
    Nat Biomed Eng; 2021 Aug; 5(8):897-913. PubMed ID: 34239116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guanylin in the human pancreas: a novel luminocrine regulatory pathway of electrolyte secretion via cGMP and CFTR in the ductal system.
    Kulaksiz H; Schmid A; Hönscheid M; Eissele R; Klempnauer J; Cetin Y
    Histochem Cell Biol; 2001 Feb; 115(2):131-45. PubMed ID: 11444148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas.
    Boom A; Lybaert P; Pollet JF; Jacobs P; Jijakli H; Golstein PE; Sener A; Malaisse WJ; Beauwens R
    Endocrine; 2007 Oct; 32(2):197-205. PubMed ID: 18040894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
    Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purinergic regulation of CFTR and Ca(2+)-activated Cl(-) channels and K(+) channels in human pancreatic duct epithelium.
    Wang J; Haanes KA; Novak I
    Am J Physiol Cell Physiol; 2013 Apr; 304(7):C673-84. PubMed ID: 23364268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective regulation of gap junctional coupling in cystic fibrosis pancreatic duct cells.
    Chanson M; Scerri I; Suter S
    J Clin Invest; 1999 Jun; 103(12):1677-84. PubMed ID: 10377174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Culture and Imaging of Human Nasal Epithelial Organoids.
    Liu Z; Anderson JD; Natt J; Guimbellot JS
    J Vis Exp; 2021 Dec; (178):. PubMed ID: 34978285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic fibrosis and the pancreas: recent scientific advances.
    Nousia-Arvanitakis S
    J Clin Gastroenterol; 1999 Sep; 29(2):138-42. PubMed ID: 10478873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloride channels and cystic fibrosis of the pancreas.
    Gray MA; Winpenny JP; Verdon B; McAlroy H; Argent BE
    Biosci Rep; 1995 Dec; 15(6):531-41. PubMed ID: 9156582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exocrine cell-derived microparticles in response to lipopolysaccharide promote endocrine dysfunction in cystic fibrosis.
    Constantinescu AA; Gleizes C; Alhosin M; Yala E; Zobairi F; Leclercq A; Stoian G; Mitrea IL; Prévost G; Toti F; Kessler L
    J Cyst Fibros; 2014 Mar; 13(2):219-26. PubMed ID: 24095207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immuno and functional characterization of CFTR in submandibular and pancreatic acinar and duct cells.
    Zeng W; Lee MG; Yan M; Diaz J; Benjamin I; Marino CR; Kopito R; Freedman S; Cotton C; Muallem S; Thomas P
    Am J Physiol; 1997 Aug; 273(2 Pt 1):C442-55. PubMed ID: 9277342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
    Reddy MM; Quinton PM
    JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel gene delivery method transduces porcine pancreatic duct epithelial cells.
    Griffin MA; Restrepo MS; Abu-El-Haija M; Wallen T; Buchanan E; Rokhlina T; Chen YH; McCray PB; Davidson BL; Divekar A; Uc A
    Gene Ther; 2014 Feb; 21(2):123-30. PubMed ID: 24257348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of carbonic anhydrase IV to plasma membranes is altered in cultured human pancreatic duct cells expressing a mutated (deltaF508) CFTR.
    Fanjul M; Salvador C; Alvarez L; Cantet S; Hollande E
    Eur J Cell Biol; 2002 Aug; 81(8):437-47. PubMed ID: 12234015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanol and its non-oxidative metabolites profoundly inhibit CFTR function in pancreatic epithelial cells which is prevented by ATP supplementation.
    Judák L; Hegyi P; Rakonczay Z; Maléth J; Gray MA; Venglovecz V
    Pflugers Arch; 2014 Mar; 466(3):549-62. PubMed ID: 23948742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.